Technetium Tc99m etarfolatide

N/A

Report date: 2025/11/19 17:58:07

NME

Base Information

Drug NameTechnetium Tc99m etarfolatide

Drug Alias Name99mTc-etarfolatideFolcepriFolateScanNMK-2099mTc-EC20 +[6]

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5]

Mechanisms of ActionSingle-photon emission-computed tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursLupus Erythematosus, SystemicMultiple Sclerosis +[19]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEndocyte Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursLupus Erythematosus, SystemicMultiple Sclerosis +[19]

Other Information

ATC CodeN/A